SCHEMBL249334

SCHEMBL249334

COCCCc1nc2cc(F)ccc2cc1CCNc1ncnc2[nH]cnc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 9/20 0.39
HTT P42858 4/20 0.37
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.35
MAPT P10636 2/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
NR2F2 P24468 1/20 0.35
MAPK1 P28482 1/20 0.35
TP53 P04637 1/20 0.35
NPC1 O15118 1/20 0.34
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
PDE10A Q9Y233 1/20 0.33
HTR1A P08908 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249677 0.90 PIK3CD (0.36) IP6K1HTTLMNASMN1; SMN2MAPT
SCHEMBL250361 0.89 PIK3CD (0.38) HTTLMNASMN1; SMN2MAPTTSHR
SCHEMBL249910 0.88 PIK3CD (0.37) HTTLMNASMN1; SMN2MAPTTSHR
SCHEMBL246483 0.88 MAP4K4 (0.38) IP6K1HTTLMNASMN1; SMN2MAPT
SCHEMBL249625 0.86 PIK3CD (0.35) IP6K1HTTLMNASMN1; SMN2MAPT
SCHEMBL249593 0.86 HTT (0.34) HTTLMNASMN1; SMN2MAPTTSHR
SCHEMBL248515 0.85 HTT (0.34) IP6K1HTTLMNASMN1; SMN2MAPT
SCHEMBL248495 0.84 PIK3CD (0.38) IP6K1HTTLMNASMN1; SMN2MAPT
SCHEMBL248311 0.83 MAP4K4 (0.38) HTTLMNASMN1; SMN2MAPTKDM4E
SCHEMBL248767 0.82 PIK3CD (0.37) IP6K1HTTLMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588469-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003271-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed